Dynavax Technologies

2929 Seventh Street, Suite 100
94710 Berkeley
USA

Phone

dynavax.com

Contact

About Dynavax Technologies

We are committed to utilizing the immune system to prevent and fight disease.

News about Dynavax Technologies

10-Nov-2009 | people

Dynavax Appoints Francis R. Cano, Ph.D. to Board of Directors

Dynavax Technologies Corporation announced that Francis R. Cano, Ph.D. has been appointed to Dynavax’s Board of Directors effective November 3, 2009. Dr. C ...

Read news

20-Aug-2007 | research and development

Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists

Dynavax Technologies Corporation announced that the U.S. Patent Office has issued the company a broad composition of matter patent covering the company's ...

Read news

24-Aug-2006 | research and development

Dynavax's Flu Vaccine Shows Immunity to Divergent and Potentially Pandemic Flu Strains in Preclinical Tests

Conjugation of TLR9 Agonists to Conserved Viral Proteins Shows Protection Against 'Antigenic Shift'

Read news

29-Mar-2006 | business & finance

Crucell to sell Rhein Biotech GmbH to Dynavax

Crucell N.V. announced plans to divest biopharmaceutical and vaccine manufacturer Rhein Biotech GmbH in a cash transaction. Rhein Biotech GmbH is part of ...

Read news

Show more news about Dynavax Technologies